Skip to main content

Table 2 Biochemical properties of the objectives of the three groups

From: Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications

 

T2DM

T2DM + MC

Control

FPG (mg/dl)

9.42 ± 4.20★

8.76 ± 3.16★

5.11 ± 1.20

Insulin (mIU/ml)

24.7 ± 81.7★

22.8 ± 49.1★

9.7 ± 10.2

HOMA-IR

7.14 ± 21.18★

9.97 ± 21.64★●

3.41 ± 2.72

HbA1c (%)

8.07 ± 1.97★

8.55 ± 2.17★

5.58 ± 0.41

TC (mg/dl)

4.29 ± 2.12

4.35 ± 0.87

4.01 ± 1.03

LDL-C (mg/dl)

2.41 ± 0.75

2.39 ± 1.17

2.62 ± 0.93

HDL-C (mg/dl)

1.18 ± 0.45★

1.03 ± 0.50★

1.79 ± 0.59

TG (mg/dl)

1.74 ± 1.24

1.81 ± 1.41

1.72 ± 0.69

hs-CRP (mg/dl)

5.15 ± 4.30★

6.02 ± 6.86★

2.31 ± 3.84

Vaspin (ng/ml)

592.5 ± 45.2★

177.6 ± 54.8▲●

381.9 ± 32.6

  1. FPG fasting plasma glucose, HOMA-IR homeostasis model assessment of insulin resistance, HbA1c glycosylated hemoglobin A1C, TC total cholesterol, LDL-C low density lipoprotein-cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, hs-CRP C-reactive protein
  2. Compared with the T2DM group: ● P < 0.05; Compared with the control group: ★ P < 0.05, ▲ P < 0.01
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us